Long-term results of coronary artery bypass surgery in patients with severely depressed left ventricular function

I Shapira1, A Isakov, V Yakirevich

  • 1Department of Medicine H, Tel Aviv E. Sourasky Medical Center, Tel Aviv University, Israel.

Chest
|December 1, 1995
PubMed

Insights

Coronary artery bypass grafting (CABG) offers good survival and improved heart function for patients with severe left ventricular dysfunction (LVD). This surgery effectively reduces angina and heart failure symptoms, enhancing overall quality of life.

Area of Science:

  • Cardiovascular Surgery
  • Cardiac Rehabilitation
  • Heart Failure Management

Background:

  • Severe left ventricular dysfunction (LVD) poses significant challenges in cardiac surgery.
  • Coronary artery bypass grafting (CABG) outcomes in this high-risk group require thorough evaluation.

Purpose of the Study:

  • To assess the medium- and long-term results of CABG in patients with severe LVD.
  • To evaluate the impact of CABG on survival, clinical status, and left ventricular function.

Main Methods:

  • Prospective evaluation of 74 patients with LVEF ≤ 30% undergoing isolated CABG.
  • Clinical follow-up and radionuclide angiography for assessment of survival, angina, CHF, and LVEF.

Main Results:

  • Achieved excellent survival rates (83.8% at 7 years).
  • Significant improvements in angina (2.9 to 1.4) and CHF (2.7 to 1.8) classes.
  • Mean LVEF improved from 23.5% to 35.7% post-CABG.

Conclusions:

  • CABG is a safe and effective treatment for patients with coronary artery disease and severe LVD.
  • The procedure leads to significant improvements in survival, functional status, and cardiac function.
  • Internal mammary artery (IMA) grafting is a safe and viable option in this patient cohort.
Abstract

Related Concept Videos

Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
Heart Failure VI: Adjunct Therapies01:22

Heart Failure VI: Adjunct Therapies

Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
Cardiomyopathy VII: Pre and Post Operative Nursing Management01:28

Cardiomyopathy VII: Pre and Post Operative Nursing Management

Patients with hypertrophic cardiomyopathy (HCM) and left ventricular outflow tract (LVOT) obstruction who remain symptomatic despite optimal medical therapy may undergo a septal myectomy (Morrow procedure). This procedure involves excising a portion of the hypertrophied septum below the aortic valve using a heart-lung machine to improve blood flow through the LVOT. Effective preoperative and postoperative nursing management ensures successful patient outcomes, minimizes complications, and...